Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

REF Program Helps Meet Critical Need for Pediatric Rheumatologists

Staff  |  June 13, 2011

It’s not far-fetched to assume that most medical students have no exposure to pediatric rheumatology while in school. The ACR Research and Education Foundation (REF) is hoping to change that.

Filed under:Education & TrainingFrom the CollegeResearch Rheum Tagged with:ACR Research and Education FoundationCareer developmentEducationResearch

The Classification Challenge of Pediatric Spondylarthritis

Robert A. Colbert, MD, PhD  |  April 1, 2010

Condition often confused with other disorders

Filed under:Axial SpondyloarthritisConditionsPediatric Conditions Tagged with:Diagnostic CriteriaJuvenile idiopathic arthritisPathogenesisPediatricPediatric SpondyloarthritisTreatment

Annual Meeting Opportunities for Pediatric Rheumatologists

Staff  |  July 1, 2009

The ACR/ARHP Annual Scientific Meeting is the premier event for specialists in the field of rheumatology, and this year’s planning committee is committed to providing attendees with educational opportunities specifically tailored to their areas of interest.

Filed under:Axial SpondyloarthritisFrom the CollegeSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual Meetingaxial spondyloarthritis (SpA)EducationPediatrics

Pediatric BOOST

Terry Hartnett  |  March 1, 2008

Many innovative programs aim to meet the increasing need for pediatric rheumatologists

Filed under:Education & TrainingPractice SupportResearch RheumWorkforce Tagged with:AC&RFellowsPediatric RheumatologyResearchRheumatology Workforce Study

2008 Keystone Pediatric Rheumatology Symposium

Staff  |  January 1, 2008

In 1976, a group of rheumatologists convened in Park City, Utah, to discuss the rheumatic diseases of childhood. In many ways, this was the beginning of the pediatric rheumatology subspecialty in the United States.

Filed under:Education & TrainingFrom the CollegeMeeting ReportsPractice SupportResearch Rheum Tagged with:AC&RBasic researchEducationMeetingPediatric Rheumatology

FDA Approves Ustekinumab-stba for All Forms & Dosages as Its Reference Product

Michele B. Kaufman, PharmD, BCGP  |  July 16, 2025

Ustekinumab-stba (Steqeyma) now has FDA approval for all forms and dosages of its reference product, ustekinumab (Stelara), including a subcutaneous injection to treat pediatric patients with plaque psoriasis or psoriatic arthritis.

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic Arthritis Tagged with:Biologics & BiosimilarsBiosimilarsFDAFDA approvalPsA Resource CenterPsoriasisPsoriatic Arthritisustekinumabustekinumab-stba

New Analysis Reveals More Potential Contributors to Takayasu Arteritis

Bryn Nelson, PhD  |  June 8, 2025

Recent research led to development of a cumulative genetic risk score for Takayasu arteritis, identifying differing susceptibility between groups with different genetic ancestries.

Filed under:ConditionsResearch RheumVasculitis Tagged with:genetic susceptibilitygeneticsHLA-B*52large-vessel vasculitispatient communicationphysician-patient communicationPrecision MedicineTakayasu arteritistherapeutic targets

Sjögrens Syndrome: The Need to Bridge Patient Symptoms & Objective Findings

New Discoveries in Sjögren’s Disease

Vanessa Caceres  |  June 1, 2025

Although dryness and other symptoms of Sjögren’s disease continue to vex patients, the prospect of new treatments and a recent name change demonstrate advances in patient care.

Filed under:ConditionsSjögren’s Disease Tagged with:ACR on AirACR on Air podcastDry eyeeyemouthpatient careSjogren'sskin

Belimumab Promising for Children with Lupus Nephritis

Michele B. Kaufman, PharmD, BCGP  |  May 31, 2025

In late July 2022, the U.S. Food & Drug Administration (FDA) approved belimumab (Benlysta) for the treatment of children with active lupus nephritis aged 5 to 17 years old receiving standard therapy.1 Despite recent advances in treatment options for patients with systemic lupus erythematosus (SLE), those with kidney involvement may develop endstage renal disease and…

Filed under:ConditionsDrug UpdatesPediatric ConditionsSystemic Lupus Erythematosus Tagged with:belimumabFDA approvalLupus nephritis supplementPediatric

Kidney Biopsy in Lupus Nephritis

Ruth Jessen Hickman, MD  |  May 31, 2025

As part of a session on lupus nephritis at ACR Convergence 2023, Simone Appenzeller, MD, PhD, shared perspectives on the importance of biopsy to inform the diagnosis, prognosis and treatment of the condition, with an emphasis on childhood disease. Prompt diagnosis and treatment of lupus nephritis is perhaps even more important for children than for…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:kidney biopsyLupus nephritis supplement

  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 109
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences